R&D-backed OEM/ODM formulas manufactured under strict cGMP guidelines for global distribution
As the global health and wellness sector pivots toward science-backed efficacy and complex active ingredient synergies, selecting a Contract Development and Manufacturing Organization (CDMO) is no longer merely a procurement task—it is a core strategic decision. China has rapidly evolved from a raw ingredient supplier into the world's most advanced center for dietary supplement R&D, enzymatic bio-synthesis, and precision formulation engineering.
Operating over 30+ years of continuous manufacturing research, our state-of-the-art production hubs combine pharmaceutical-grade analytical rigor with high-throughput industrial scaling. Our facilities comply with stringent international regulatory frameworks including US FDA 21 CFR Part 111 (Dietary Supplements) and Part 117 (Preventive Controls for Human Food), SQF Edition 9, ISO 22000, Halal, Kosher, and USDA Organic handling standards.
Our integrated facilities operate continuous automation for six primary dosage platforms. By eliminating multi-vendor hand-offs, we guarantee full lot traceability, minimal batch-to-batch variance, and rapid market entry within a 90-day window from prototype sign-off to export container loading.
Pectin-based and gelatin-free formulations optimized for thermal stability during cross-border transit. Advanced active loading up to 15% per gummy without sugar crystallization or off-notes.
High-solubility peptide hydrolysates, plant proteins, and stick-pack powders featuring instantized dispersion technology, moisture barrier packaging, and uniform particle sizing.
HPMC vegetable shells, softgels for lipid-soluble nutrients (CoQ10, Omega-3s, Vitamin D3/K2), and multi-layer enteric capsules designed for target gut dissolution.
Pioneering buccal absorption formats for nootropics and cellular enhancers (L-Theanine, Caffeine, Nicotinamide precursors), bypassing hepatic first-pass metabolism.
| Manufacturing Parameter | Pilot Line (R&D Stage) | Commercial Export Scale | Quality Assurance Protocols |
|---|---|---|---|
| Capsule Production | 10,000 – 50,000 units | 5,000,000 units/day | In-line metal detection, weight sorting, disintegration testing |
| Gummy Deposit | 50 kg batch size | 12,000 kg/day line output | Brix monitoring, water activity (Aw) control, potency recovery assay |
| Powder Blending | 100 kg pilot run | 15 metric tons/day | NIR blend uniformity, particle size sieve analysis, microbial screen |
| Peptide Enzymatic Synthesis | 500 L reactor | 20,000 L continuous extraction | HPLC molecular weight distribution, purity profiling (>98%) |
Navigating global nutraceutical sourcing requires understanding broader macroeconomic, regulatory, and scientific shifts. B2B buyers, private-label brands, and pharmaceutical distributors must align their supply chains with the following three strategic vectors:
Recent supply chain volatility has highlighted the risks of single-region reliance. Leading global supplement brands are adopting a hybrid manufacturing model: utilizing China's high-capacity R&D hubs for raw material bio-synthesis, extract purification, and primary blending, while deploying secondary finishing plants in target sales territories (such as the US or Europe) to hedge against tariff shifts and speed up local distribution.
Consumer expectations have transitioned from crude botanical powders toward clinically validated, standardized extracts. For example, crude walnut powder is rapidly being replaced by bio-hydrolyzed Walnut Peptides with specific molecular weight profiles (under 1,000 Daltons) that pass directly through the intestinal epithelium to support cognitive micro-circulation. China's bio-refining infrastructure leads this global movement.
E-commerce platforms like Amazon, Walmart Marketplace, and TikTok Shop have intensified compliance controls. Third-party testing requirements now mandate ISO 17025-accredited Certificates of Analysis (COAs) covering heavy metals, micro-pathogens, pesticide residues, and adulterant screens. Working directly with a audited China CDMO guarantees that compliance documentation is generated at the batch origin point, averting costly import rejections.
To capture market share in high-margin categories, global brand owners must prioritize research-backed active ingredients. Our internal R&D laboratories highlight three rapid-growth formulation verticals for 2025–2030:
Cellular aging research emphasizes replenishing intracellular NAD+ pools. Advanced formulations blend NAD+ precursors (such as NMN or high-purity NAD+ molecules) with synergistic sirtuin activators like Trans-Resveratrol, Fisetin, and Spermidine. Utilizing micro-pellet capsule delivery prevents premature gastric degradation.
Mental focus products are moving away from synthetic stimulant heavy powders toward clean, sustained-release nootropics. Combining Citicoline (CDP-Choline), L-Theanine, and bio-available peptides into sublingual oral pouches bypasses digestive breakdown, providing rapid cognitive activation for high-performance professionals.
Humanization of pet nutrition has driven demand for veterinary-grade pet supplements. Formulating multi-strain pet probiotics stabilized via micro-encapsulation ensures viable Colony Forming Units (CFUs) reach the animal lower digestive tract, supporting appetite regulation, joint vitality, and skin coat health.
Below are detailed answers to the most common regulatory, technical, and commercial questions raised by international procurement managers during facility qualification.
Building a resilient supplement brand requires a CDMO partner that combines technical mastery with international business transparency. Our manufacturing framework delivers key competitive advantages for global buyers:
Continuous investment in enzymatic hydrolysis, botanical extraction, and cell biology research empowers our partners with proprietary ingredient innovations before they hit mainstream markets.
From raw material quarantine to finished product release, every batch undergoes 14 distinct quality checkpoints, eliminating risk before goods depart our loading docks.
Our dedicated regulatory export department manages customs clearance, FDA facility registration updates, tariff coding (HS Code alignment), and multi-modal freight logistics worldwide.
Whether you require custom formulation development, pilot batch prototyping, or high-volume CDMO contract manufacturing, our engineering team is ready to deliver.
